Skip to content
StockMarketAgent
Sector pending / Electromedical and Electrotherapeutic ApparatusUpdated 2026-05-10 22:07 UTC

BIT/1TMDX stock hub

BIT/1TMDX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

BIT/1TMDXis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
2B
Borsa Italiana
Market data

Live price

Current market quote for this ticker.

Current price
BIT/1TMDX
In the news

Latest news · BIT/1TMDX

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E31.1
P25 n/aP50 n/aP75 n/a
Trailing P/E13.4
P25 n/aP50 n/aP75 n/a
ROE45.2
P25 n/aP50 n/aP75 n/a
ROIC13.5
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All BIT/1TMDX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
184
Groups with data
11
Currency
USD
Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
United States
Country code
IT
Employees
898
Employees Change
170%
Employees Change Percent
23.35
Enterprise value
EUR 2.3B
Exchange
Borsa Italiana
Financial currency
USD
First seen
2026-05-10
Industry
Electromedical and Electrotherapeutic Apparatus
Last refreshed
2026-05-10
Market cap
EUR 2B
Price
EUR 57.96
Price currency
EUR
Rev Per Employee
614,150.78x
Sic
3845
Symbol
bit/1TMDX
Website
https://www.transmedics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

12
MetricValue
Earnings Yield
7.49%
EV Earnings
15.65x
EV/EBIT
29.08x
EV/EBITDA
20.57x
EV/FCF
17.77x
EV/Sales
4.32x
FCF yield
6.59%
Forward P/E
31.14x
P/B ratio
4.65x
P/E ratio
13.36x
P/S ratio
3.61x
PE Ratio3 Y
258.26x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

22
MetricValue
EBIT Margin
14.85%
EBITDA Margin
19.71%
FCF margin
23.8%
Gross margin
59.09%
Gross Profit
EUR 325.9M
Gross Profit Growth
29.41%
Gross Profit Growth Q
14.66%
Gross Profit Growth3 Y
66.14%
Gross Profit Growth5 Y
86.65%
Net Income
EUR 149.1M
Net Income Growth
251.23%
Net Income Growth Q
-71.52%
Pretax Margin
14.05%
Profit Margin
27.04%
Profit Per Employee
EUR 166,046
ROA
5.19
Roa5y
-3.31
ROCE
7.03
ROE
45.22
Roe5y
-4.34
ROIC
13.49
Roic5y
-59.58

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

8
MetricValue
Cagr1y
-29.98%
EPS Growth
216.8
EPS Growth Q
-71.52
OCF Growth
345.96%
Revenue Growth
30.25x
Revenue Growth Q
21.18x
Revenue Growth3 Y
74.76x
Revenue Growth5 Y
90.78x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
EUR 0.56
Assets
EUR 1.2B
Cash
EUR 400.5M
Current Assets
EUR 525.1M
Current Liabilities
EUR 77.9M
Debt
EUR 748.8M
Debt EBITDA
EUR 6.47
Debt Equity
EUR 1.75
Debt FCF
EUR 5.7
Equity
EUR 428.5M
Interest Coverage
5.4
Liabilities
EUR 816M
Long Term Assets
EUR 719.3M
Long Term Liabilities
EUR 738M
Net Cash
EUR -348.4M
Net Cash By Market Cap
EUR -17.49
Net Debt EBITDA
EUR 3.2
Net Debt Equity
EUR 0.81
Net Debt FCF
EUR 2.65
Tangible Book Value
EUR 418.4M
Tangible Book Value Per Share
EUR 12.11

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
6.74
Inventory Turnover
5.11
Net Working Capital
EUR 73M
Quick ratio
6.01
Working Capital
EUR 457.4M
Working Capital Turnover
EUR 1.13

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-8.45%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

32
MetricValue
1Y total return
-29.97%
200-day SMA
104.7
50-day SMA
97.23
50-day SMA vs 200-day SMA
50under200
All Time High
129.7
All Time High Change
-55.3%
All Time High Date
2025-12-01
All Time Low
58
All Time Low Change
-0.07%
All Time Low Date
2026-05-08
ATR
3.9
Ch YTD
-44.72
High
60.16
High52
129.7
High52 Date
2025-12-01
High52ch
-55.3%
Low
58
Low52
57.96
Low52 Date
2026-05-08
Low52ch
0%
Ma50ch
-40.39%
Price vs 200-day SMA
-44.65%
RSI
22.03
RSI Monthly
0
RSI Weekly
31.72
Sharpe ratio
-0.37x
Sortino ratio
-0.43
Total Return
-8.45%
Tr YTD
-44.72
Tr1m
-37.35%
Tr1w
-30.88%
Tr3m
-49.14%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

4
MetricValue
Operating Income
EUR 81.9M
Operating Income Growth
79.82
Operating Income Growth Q
-51.55
Operating margin
14.85

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
33,442,838%
Shares Insiders
3.2%
Shares Institutions
109.35%
Shares Qo Q
-11.57%
Shares Yo Y
8.45%
Short Ratio
6.74

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

54
MetricValue
Adjusted FCF
EUR 98.4M
Average Volume
417.95x
Bv Per Share
12.4
CAPEX
EUR -59.7M
Ch1m
-37.35
Ch1w
-30.88
Ch1y
-29.97
Ch3m
-49.14
Ch6m
-42.7
Change
-11.35%
Change From Open
-3.66
Close
65.38
Days Gap
-7.98
Depreciation Amortization
26,212,201.3
Dollar Volume
133,655.8
Earnings Date
2026-05-05
EBIT
EUR 81.9M
EBITDA
EUR 108.7M
EPS
EUR 3.87
F Score
5
FCF
EUR 131.3M
FCF EV Yield
5.63x
Financing CF
15,256,674
Fiscal Year End
December
Founded
1,998
Goodwill
9,793,113.1
Graham Number
34.88496
Graham Upside
-39.81
Income Tax
EUR -71.6M
Investing CF
-59,730,951
Is Primary Listing
0
Last Earnings Date
2026-05-05
Last Report Date
2026-03-31
Ma150
106.4
Ma150ch
-45.53%
Ma20
88.39
Ma20ch
-34.43%
Net CF
147,036,838
Open
60.16
P FCF Ratio
15.17
P OCF Ratio
10.43
Position In Range
-1.85
Ppne
594,399,315
Price Date
2026-05-08
Price EBITDA
EUR 18.32
Ptbv Ratio
4.76
Relative Volume
5.52x
Revenue
551,507,397x
SBC By Revenue
5.95x
Share Based Comp
32,831,642
Tax By Revenue
-12.99x
Tr6m
-42.7%
Volume
2,306
Z Score
3.46
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does BIT/1TMDX pay a dividend?

Capital-return profile for this ticker.

Performance

BIT/1TMDX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-30.0%
S&P 500 1Y: n/a
3Y total return
n/a
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns BIT/1TMDX?

Insider, institutional, and short-interest positioning.

Institutional ownership
+109.4%
Share of float held by funds and institutions
Insider ownership
+3.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
6.7 days to cover
Y/Y dilution
+8.4%
Negative means the company is buying back shares.
Technical

BIT/1TMDX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
22.0
Below 30: short-term oversold
Price vs 200-day MA
-44.7%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
-0.37
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About BIT/1TMDX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bit/1TMDX stock rating?

bit/1TMDX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bit/1TMDX analysis?

The full report lives at /stocks/bit/1TMDX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bit/1TMDX?

The latest report frames bit/1TMDX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bit/1TMDX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.